Swiss National Bank - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 115 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$591,000
-19.7%
116,2000.0%0.00%
Q2 2021$736,000
-18.0%
116,2000.0%0.00%
-100.0%
Q1 2021$898,000
+45.8%
116,200
+23.6%
0.00%
Q4 2020$616,000
+1.5%
94,000
+3.0%
0.00%
Q3 2020$607,000
-20.2%
91,3000.0%0.00%
-100.0%
Q2 2020$761,000
+14.1%
91,300
+5.1%
0.00%0.0%
Q1 2020$667,000
-7.6%
86,9000.0%0.00%0.0%
Q4 2019$722,000
+16.6%
86,900
+3.6%
0.00%0.0%
Q3 2019$619,000
-34.2%
83,9000.0%0.00%0.0%
Q2 2019$941,000
+12.4%
83,900
+7.7%
0.00%0.0%
Q1 2019$837,000
-26.6%
77,900
+3.2%
0.00%0.0%
Q4 2018$1,140,000
-15.4%
75,500
+3.7%
0.00%
-50.0%
Q3 2018$1,347,000
-2.1%
72,800
+20.9%
0.00%0.0%
Q2 2018$1,376,000
+35.8%
60,200
+69.1%
0.00%
+100.0%
Q1 2018$1,013,000
+43.7%
35,600
+6.6%
0.00%0.0%
Q4 2017$705,000
+16.1%
33,4000.0%0.00%0.0%
Q3 2017$607,000
+17.2%
33,4000.0%0.00%0.0%
Q2 2017$518,000
+11.9%
33,400
+24.6%
0.00%0.0%
Q1 2017$463,000
+87.4%
26,800
+19.1%
0.00%
Q4 2016$247,000
-30.0%
22,5000.0%0.00%
-100.0%
Q3 2016$353,000
+53.5%
22,5000.0%0.00%
Q2 2016$230,00022,5000.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Burrage Capital Management LLC 476,110$3,956,0002.65%
MPM BioImpact LLC 855,437$7,109,0002.52%
Exane Asset Management 87,876$730,250,0000.90%
Congress Park Capital LLC 94,661$787,0000.58%
Perceptive Advisors 3,253,923$27,040,0000.54%
BVF INC/IL 766,148$6,367,0000.48%
RTW INVESTMENTS, LP 1,039,593$8,639,0000.33%
EcoR1 Capital, LLC 410,000$3,407,0000.31%
DAFNA Capital Management LLC 100,000$831,0000.28%
HARBOURVEST PARTNERS LLC 79,193$658,0000.27%
View complete list of CYTOMX THERAPEUTICS INC shareholders